Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

The Role of Lysosomal Acid Lipase in Atherosclerotic Lesion Smooth Muscle Cells

FY 2018-19

Summary
BACKGROUND: Heart attack and stroke together are the leading cause of death in Canada and the world. They result from atherosclerosis, or hardening of the arteries, a disease in which cholesterol builds up in artery walls. This causes arteries to become inflamed and blocked. Our team discovered that smooth muscle cells (SMCs), a type of cell in the artery wall, have low levels of a protein called Lysosomal Acid Lipase (LAL) that is important for processing and expelling excess cholesterol. We therefore believe that SMCs are resistant to expelling cholesterol, and that this contributes to atherosclerosis even when blood cholesterol is lowered by diet and medications. Because more than half the cells in hardened artery walls are SMCs, developing strategies to release their cholesterol may be very effective in treating atherosclerosis. GOAL: Previously, we showed that giving LAL to human SMCs in a dish increases their cholesterol export. The goal of my project is to test if increasing the amount of LAL in mouse SMCs in a dish will also increase cholesterol export. APPROACH: First, I will confirm that mouse SMCs, like human SMCs, have low LAL, by measuring LAL levels in aortic arches (a common site of artery hardening) from mice that have atherosclerosis. Second, I will increase the amount of LAL in mouse SMCs in a dish using a gene manipulation technique. Third, I will determine if this increase in LAL causes an increase in cholesterol export from the SMCs. OUTCOMES: I expect that mouse SMCs in the aortic arch will have low levels of LAL, and that mouse SMCs, like human SMCs, will release more cholesterol when LAL levels are increased. These results would support studying the effect of increasing LAL in SMCs in live mice on treating and preventing atherosclerosis.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406411
Name
Besler Katrina
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Role of Lysosomal Acid Lipase in Atherosclerotic Lesion Smooth Muscle Cells
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atherosclerosis; Atp Binding Cassette Transporter A1; Cholesterol; Crispr Cas9; Foam Cells; Ldl; Lysosomal Acid Lipase; Macrophages; Mouse Model; Smooth Muscle Cells
Abstract
BACKGROUND: Heart attack and stroke together are the leading cause of death in Canada and the world. They result from atherosclerosis, or hardening of the arteries, a disease in which cholesterol builds up in artery walls. This causes arteries to become inflamed and blocked. Our team discovered that smooth muscle cells (SMCs), a type of cell in the artery wall, have low levels of a protein called Lysosomal Acid Lipase (LAL) that is important for processing and expelling excess cholesterol. We therefore believe that SMCs are resistant to expelling cholesterol, and that this contributes to atherosclerosis even when blood cholesterol is lowered by diet and medications. Because more than half the cells in hardened artery walls are SMCs, developing strategies to release their cholesterol may be very effective in treating atherosclerosis. GOAL: Previously, we showed that giving LAL to human SMCs in a dish increases their cholesterol export. The goal of my project is to test if increasing the amount of LAL in mouse SMCs in a dish will also increase cholesterol export. APPROACH: First, I will confirm that mouse SMCs, like human SMCs, have low LAL, by measuring LAL levels in aortic arches (a common site of artery hardening) from mice that have atherosclerosis. Second, I will increase the amount of LAL in mouse SMCs in a dish using a gene manipulation technique. Third, I will determine if this increase in LAL causes an increase in cholesterol export from the SMCs. OUTCOMES: I expect that mouse SMCs in the aortic arch will have low levels of LAL, and that mouse SMCs, like human SMCs, will release more cholesterol when LAL levels are increased. These results would support studying the effect of increasing LAL in SMCs in live mice on treating and preventing atherosclerosis.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Besler, Katrina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~